VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,742 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post Traumatic Stress Disorder, with 45 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,108 of 1,180 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (93.9%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,668 total, page 18 of 34
Enhancement of PTSD Treatment With Computerized Executive Function Training
NCT03260127
Testosterone and Long Pulse Stimulation After SCI
NCT03345576
Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer
NCT03298087
Incline Training to Personalize Motor Control Interventions After Stroke
NCT03561246
Metabolic Effects of Natriuretic Peptide Hormones
NCT03397966
Arm Exercise Versus Pharmacologic Stress Testing for Clinical Outcome
NCT03449888
Regulation of Insulin Secretion by the GLP-1 Receptor
NCT02844907
Non-Pharmacological Treatments for Insomnia in Chronic Traumatic Brain Injury
NCT03261674
Treating Sleep Apnea in Women Veterans
NCT03377452
Improving Housing Outcomes for Homeless Veterans
NCT03646149
Cognitive Training for PTSD
NCT03316196
Prospective RCT Of Water Exchange (WE) vs. WE Plus Cap-Assisted Colonoscopy
NCT03160859
Online and Shared Decision-Making Interventions to Engage Service Men and Women in Post-Deployment Mental Health Care
NCT03539068
Peer Support for Exercise in Older Veterans With Psychotic Disorders
NCT02958007
Exercise and NO in HFrEF
NCT03136029
Optimizing Treatment Response in VA Specialized Intensive/Inpatient PTSD Programs
NCT03533608
Restoring High Dimensional Hand Function to Persons With Chronic High Tetraplegia
NCT03482310
Robotic Training for Stroke Neurorehabilitation
NCT02639390
A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD
NCT02632552
Low Dose Naltrexone for Chronic Pain From Arthritis
NCT03008590
Peer-Delivered Whole Health Coaching for Veterans With PTSD
NCT03364192
Optimizing Function and Independence Through iHI-FIVES
NCT03474380
Pivot-Flex Foot: Optimal Coupling Ratio Between Transverse and Sagittal-plane Motions Using a Torsionally Adaptive Prosthesis for Individuals With Lower Limb Amputation
NCT03532100
Ezetimibe as a Safe and Efficacious Treatment for Chronic Hepatitis C
NCT02971033
Transcranial Magnetic Stimulation for the Treatment of Veterans With Alcohol Use Disorders
NCT03191266
Acupuncture for PTSD
NCT02869646
Modulation of the Intestinal Microbiome by a High Protein Diet
NCT04812964
tDCS Plus Virtual Reality for PTSD
NCT03372460
Precision Assessment of Platelet Rich Plasma for Joint Preservation
NCT03460236
Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation
NCT03265964
Medications for Opioid Use Disorders (MOUD) Via Telemedicine
NCT03566459
Spatial Cognitive Training
NCT03423654
Hearing Aids and the Brain
NCT03279510
Financial vs. Non-Financial Rewards for Weight Loss and Weight Maintenance
NCT02957539
Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease
NCT03149809
CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes
NCT02535923
Self-management of Blood Pressure Medication for Hypertensive Veterans
NCT03224624
DVD Lifestyle Intervention
NCT03260140
Neurobiology of Alcohol and Nicotine Co-Addiction
NCT03338933
Transfusion Trigger After Operations in High Cardiac Risk Patients
NCT03229941
Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease
NCT03607695
INcreasing Veteran EngagemeNT to Prevent Diabetes (INVENT)
NCT03403231
Stimulant Oxytocin Study
NCT03016598
Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
NCT03012529
Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families
NCT03256227
The Peer Assisted Lifestyle Intervention
NCT03163264
Weight Loss Treatment for Veterans With Binge Eating
NCT03234881
Cervical Electrical Stimulation for ALS
NCT03411863
Psychosocial Rehabilitation After Moral Injury and Loss With Adaptive Disclosure
NCT03056157
Development of a Weight Maintenance Intervention for Bariatric Surgery Patients
NCT03246672
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: Post Traumatic Stress Disorder (45 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
VA Office of Research and Development: open-pipeline peers nationwide
Peers matched on 1,668 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
VA Office of Research and Development sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,668 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- Washington University School of Medicine · 1,502 trials · 14% recruiting
Sponsors near 17% open enrollment (± trial volume)
- University of South Florida · 17% recruiting · 252 trials
- ImmunityBio · 17% recruiting · 46 trials
- Old Dominion University · 17% recruiting · 23 trials
- Texas Tech University · 17% recruiting · 69 trials
Related
What to do with this VA Office of Research and Development page
1,668 registered trials is a research-attention snapshot, not an endorsement of VA Office of Research and Development or any single study.
- 291 of VA Office of Research and Development's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Post Traumatic Stress Disorder is the condition VA Office of Research and Development studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post Traumatic Stress Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. VA Office of Research and Development pipeline card: 1,668 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.